![Vaccines | Free Full-Text | Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy Vaccines | Free Full-Text | Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy](https://pub.mdpi-res.com/vaccines/vaccines-09-01392/article_deploy/html/images/vaccines-09-01392-g001.png?1637834845)
Vaccines | Free Full-Text | Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
![Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells | Nature Communications Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21383-1/MediaObjects/41467_2021_21383_Fig1_HTML.png)
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells | Nature Communications
![Evolving synergistic combinations of targeted immunotherapies to combat cancer | Nature Reviews Cancer Evolving synergistic combinations of targeted immunotherapies to combat cancer | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrc3973/MediaObjects/41568_2015_Article_BFnrc3973_Fig1_HTML.jpg)
Evolving synergistic combinations of targeted immunotherapies to combat cancer | Nature Reviews Cancer
![Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases | Cell Death & Disease Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-04688-x/MediaObjects/41419_2022_4688_Fig1_HTML.png)
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases | Cell Death & Disease
![Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine: Molecular Therapy - Oncolytics Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/5d3ee648-6ee6-43fd-854d-3017b563f23e/fx1_lrg.jpg)
Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine: Molecular Therapy - Oncolytics
![MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways | Cell Death & Disease MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-022-05352-0/MediaObjects/41419_2022_5352_Fig1_HTML.png)
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways | Cell Death & Disease
![HDM/ SCT for AL Amyloidosis - A Single Institution 12 Year Experience - Biology of Blood and Marrow Transplantation HDM/ SCT for AL Amyloidosis - A Single Institution 12 Year Experience - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/faaf248b-4274-4e34-8061-5c213362bb68/fx1_lrg.jpg)
HDM/ SCT for AL Amyloidosis - A Single Institution 12 Year Experience - Biology of Blood and Marrow Transplantation
![Vaccines | Free Full-Text | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review Vaccines | Free Full-Text | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review](https://www.mdpi.com/vaccines/vaccines-10-01727/article_deploy/html/images/vaccines-10-01727-g001.png)